Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

Recruiting N/A Interventional Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
90 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
France has one million people with heart failure (HF). Exercise intolerance, characterised by dyspnoea, is the main clinical symptom in HF patients and a key determinant of reduced quality of life. In addition to drug and surgical treatments, cardiac rehabilitation programmes have shown benefits in heart failure patients. Lasting at least 3 weeks, these programmes improve physical abilities, quali…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of stable heart failure with NYHA stage I, II or III * Participation in a cardiac rehabilitation programme * Patient agreement * Patient of legal age * Patient affiliated to the Social Security Exclusion Criteria: * Patient refusal * Minor patients * Subjects under…
Contacts

Jacques Mansourati, MD, PhD

+33298347405

jacques.mansourati@chu-brest.fr

CONTACT

Baptiste Chéhère, PhD

baptiste.chehere@univ-brest.fr

CONTACT